No Image 01Jun

by

Yuhan ups investment in biotechs for immuno-oncology drug push

No Image 01Jun

by

Yuhan to start phase-3 trial on lung cancer drug Lazertinib

No Image 01Jun

by

Profiles of Four New Stock-Billionaires

No Image 03Mar

by

Other news to note for March 2, 2021

No Image 15Sep

by

Oscotec/ADEL Announce FDA Clearance of IND Application of ADEL-Y01 for the Treatment of Alzheimer's Disease

No Image 01Jun

by

Oscotec`s SYK inhibitor Program Gets Korea Drug Fund Money

No Image 01Jun

by

Oscotec`s acute leukemia treatment wins orphan drug status from FDA

No Image 01Jun

by

Oscotec wins exception policy for continued R&D for new drugs

No Image 01Jun

by

Oscotec shares rebound on launch of US clinical trial

No Image 03Mar

by

Oscotec and Beactica Therapeutics announce license and collaboration agreement to develop new cancer drug

No Image 01Jun

by

More than half of Korean biopharma firms view R&D investments as assets.

No Image 01Jun

by

Lazertinib Shows Promising Antitumor Activity in Patients With EGFR+ NSCLC